(Q73130933)

English

Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study

scientific article published on 01 February 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

primary biliary cholangitis

0 references

Johannes P van Leeuwen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

F H Wolfhagen

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H R van Buuren

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J W den Ouden

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

W C Hop

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S W Schalm

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

H A Pols

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 February 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

325-330

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Is steroid-induced osteoporosis preventable?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical effects of bisphosphonates in involutional osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroid osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone loss and reduced osteoblast function in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical markers of bone turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary biliary cirrhosis and bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone mass in women with primary biliary cirrhosis: the relation with histological stage and use of glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone loss in autoimmune chronic active hepatitis on maintenance corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and prediction of osteopenia in chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Interpreting trials of bone-active agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone loss in response to long-term glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2897%2980048-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(97)80048-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9059953%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73130933&oldid=2154220344"